ADA: Continuous glucose monitoring lowers HbA1c in adults with type 2 diabetes not on insulin

MedicalXpress | Jun 11, 2026

For adults with type 2 diabetes (T2D) not on insulin therapy (NIT), continuous glucose monitoring (CGM) is associated with a substantial reduction in glycated hemoglobin (HbA1c), according to a study presented at the annual meeting of the American Diabetes Association, held from June 5 to 8 in New Orleans.